Overview

   

Novo Nordisk is a digital health platform whose insulin data is integrated with Roche's open ecosystem, synchronizing with its suite of digital diabetes management solutions including mySugr

On the high level the solution needs to fulfill use cases:

  • Collect data from NN Pen and deliver data via MySugr app to IPP Backends
  • Manage user consent including data sharing agreement and consent revocation
  • Share data with Novo ND Backend
  • Notify Novo ND Backend when the data is deleted